Biogen recruits Roche vet Ghosh as head of research, early development; Cell Medica raises £60 million; Aerpio bags $40M raise
→ Biogen has recruited Roche vet Anirvan Ghosh as its new SVP of research and early development. He is joining Biogen from E-Scape Bio, where he worked on Alzheimer’s and neurosciences work. And at Roche he had been global head of neuroscience discovery and biomarkers. “Biogen has been a pioneer in bringing breakthrough medicines to patients with multiple sclerosis and spinal muscular atrophy, as well as finding new approaches for Alzheimer’s disease, Parkinson’s disease, and ALS – conditions that represent some of the hardest challenges in medicine,” said Dr. Ghosh.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.